Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06021782 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Characterization of the Pudendal Nerve With Transvaginal Ultrasonography

StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 1 year 11 months later Dec 2025 → Dec 2027
See other at-risk trials from University of Virginia

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion pushed from Dec 2025 to Dec 2027 Show 6 more changesShow less
    • Enrollment closed, study ongoing
    • Study completion pushed from Dec 2026 to Dec 2027
    • Study description revised
    • Site details revised
    • Publications: details revised at 3 of 4 entries
    • Eligibility criteria expanded, about 4 words
  2. Primary completion date: Dec 2024 to Dec 2025
    • Study completion date: Dec 2024 to Dec 2026
    • Site contact updated
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a feasibility study characterizing the ability of transvaginal ultrasonography to identify the pudendal nerve. Today, the pudendal nerve block is typically accomplished through blind landmark techniques, thus limiting its success. To date, there has never been an attempt to determine if the visualization of the pudendal nerve would be possible using transvaginal ultrasound with existing technology; nor to perform this procedure transvaginally with the assistance of ultrasound.
Trial Details
NCT Number NCT06021782
Lead Sponsor University of Virginia
Conditions
(from sponsor)		 Anesthesia
Enrollment 24 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov